TG Therapeutics, Inc.
TGTX
$28.50
$0.541.93%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,812.41% | 3,215.24% | -36.82% | -4.97% | 84.52% |
| Total Depreciation and Amortization | -13.24% | -51.55% | -74.21% | -72.67% | -67.77% |
| Total Amortization of Deferred Charges | -36.52% | -44.67% | -44.91% | -32.55% | -14.79% |
| Total Other Non-Cash Items | -746.71% | -865.95% | 66.26% | 28.89% | 14.16% |
| Change in Net Operating Assets | -77.99% | -272.27% | -174.07% | -143.21% | -29.10% |
| Cash from Operations | 38.86% | -149.49% | -187.18% | -400.88% | -28.98% |
| Capital Expenditure | -375.56% | -600.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,514.03% | 173.74% | 87.44% | 91.36% | 98.04% |
| Cash from Investing | 1,431.95% | 173.44% | 87.30% | 91.23% | 97.95% |
| Total Debt Issued | -- | -100.00% | -- | -- | 879.26% |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 65.32% | 197.38% | 115.90% | -98.05% | -98.09% |
| Repurchase of Common Stock | -941.55% | -4,451.21% | -2,175,700.00% | -1,488,200.00% | -875,900.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 96.39% | -- | -- | -611.20% |
| Cash from Financing | -169.81% | -171.96% | 20,402.12% | 157.84% | 76.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -215.78% | -370.86% | 428.27% | 304.22% | 1,029.31% |